American taxpayers fund 80 to 90 percent of global pharmaceutical R&D and pay 3 to 5 times more than France, the UK, and Germany for the same drugs. A generation is now choosing between EpiPens and rent in that economy. Most Favored Nation pricing is the policy response to that arrangement, and Chris Faulkner describes himself as a libertarian on this issue — because not needing government to fix everything and requiring fairness from the system you're funding aren't contradictory positions.
显示更多